| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |